WHOLIHAN EDWARD 4
4 · Allena Pharmaceuticals, Inc. · Filed May 10, 2018
Insider Transaction Report
Form 4
WHOLIHAN EDWARD
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-05-09$1.59/sh+25,000$39,750→ 25,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-09−25,000→ 167,031 totalExercise: $1.59Exp: 2026-09-15→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]25% of the shares vested on June 20, 2017 and the remaining shares vest in 36 equal monthly installments thereafter